Search

Eyewire News: The Podcast

Eyewire News: The Podcast

09.09.26

FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA

The FDA accepts a biologics license application (BLA) for a first-of-its-kind optogenetic gene therapy for RP; a software upgrade from Heru combines several pretesting assessments into a single guided workflow; and a new FDA-approved overnight orthokeratology lens is launched in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices

View full description +

MORE EPISODES

09.09.26

FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA

09.02.26

FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop

08.26.26

EyePoint Misses Primary Endpoint in Phase 3 Trial But Sees Promise After Analysis

08.12.26

Three Major Acquisitions Announced in Ophthalmology

08.05.26

Biocon Launches Eylea Biosimilar Yesafili

07.29.26

FDA Approves Outlook's Lytenava for Wet AMD

07.22.26

PRIMA Retinal Implant Launched in EU

07.15.26

Tarsus Buys Investigational Ocular Antiseptic

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D